Correlation of irritable bowel syndrome subtype based on the Rome IV Criteria with body mass index

Year 2019, Volume: 52 Issue: 2, 149 - 152, 31.07.2019

Çağrı Akalın

Abstract

Purpose: Irritable bowel syndrome (IBS) is a disorder that is common in the community and deteriorates the quality of life. The Roma IV criteria are the current diagnostic method for the diagnosis of IBS. The aim of this study was to investigate the correlation between the subtype of IBS patients diagnosed based on the Rome IV criteria and body mass index (BMI).

 

Material and Method:The age, sex, IBS subtype (diarrhea-weighted, constipation-weighted, mixed and unsubtyped) and BMI (kg/m²) of the patients presented to the general surgery outpatient clinic of Ordu University Training and Research Hospital between June 1, 2017 - January 1, 2018 and diagnosed with IBS based on the Roma IV criteria were retrospectively analyzed.

 

Results: The mean age of 452 patients with IBS was 35.19±10.16 years (min 18-max 68 years). The BMI values were found as follows: 8 (1.8%) patients had a BMI value of <18.5 kg/m², 100 (22.1%) patients had a BMI value of 18.5-24.9 kg/m², 134 (29.6%) patients had a BMI value of 25-29.9 kg/m², 210 (46.5%) patients had a BMI value of > 30 kg/m².  It was found that of the patients, 78 (17.3%) were diarrhea-weighted, 214 (47.3%) were constipation-weighted, 125 (27.7%) were mixed, and 35 (7.7%) were unsubtyped. In the study, there was no statistically significant difference between IBS subtype and BMI (p>0.05).

 

Conclusion: In our study, there was no statistically significant correlation between IBS subtype and BMI. We are of the opinion that our study will shed light on the future studies with larger population.

Keywords

Rome IV criteria, irritable bowel syndrome, body mass index

Roma 4 kriterlerine göre irritable bağırsak sendromu subtipinin vücut kitle indeksi ile ilişkisi

Abstract

Giriş:İrritable bağırsak sendromu (İBS) toplumda sık görülen ve yaşam  kalitesini  bozan  bir hastalıktır. Roma IV kriterleri İBS tanısı için kullanılan güncel tanı metodudur. Çalışmada Roma IV kriterlerine göre tanı konulan İBS'li hastaların subtipinin ile vücut kitle indeksi (VKİ) arasındaki ilişkinin araştırılması amaçlanmıştır.

 

Gereç ve Yöntem:1 Haziran 2017‐1 Ocak 2018 tarihleri arasında Ordu Üniversitesi Eğitim ve Araştırma Hastanesi genel cerrahi polikliniğine başvurup Roma 4 kriterlerine İBS tanısı koyulan hastalar yaş, cinsiyet, İBS subtipi (diyare ağırlıklı, kabız ağırlıklı, kompleks ve sınıflandırılamayan) ile VKİ (kg/m²) retrospektif olarak analiz edildi.

 

Bulgular:İBS'li 452 hastanın yaş ortalaması 35.19±10.16 (min 18-max 68) olarak saptandı. VKİ değerleri; 8'inde (%1.8) <18.5 kg/m², 100'ünde (%22.1) 18.5‐24.9 kg/m², 134'ünde (%29,6) 25‐29.9 kg/m², 210'unda (%46.5) >30 kg/m²olarak saptandı. Hastaların 78'i (%17,3) diyare ağırlıklı, 214'ü (%47,3) kabızlık ağırlıklı, 125'i karışık ağırlıklı (%27,7) ve 35'i (%7,7) sınıflandırılamayan olarak saptandı. Çalışmada İBS subtipi ile VKİ arasında istatistiksel olarak anlamlı fark saptanmadı (p>0,05).

 

Sonuç: Çalışmamızda, İBS subtipi ile VKİ arasında istatistiksel olarak anlamlı bir ilişki bulunmamıştır. Çalışmamızın gelecekte yapılacak olan daha geniş popülasyonlu çalışmalara ışık tutacağı kanaatindeyiz.

Keywords

İrritable bağırsak sendromu, Vücut kitle indeksi, Roma 4 kriterleri

References

• 1. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007; 56(12): 1770-1798.
• 2. Chumpitazi BP, Shulman RJ. Dietary carbohydrates and childhood functional abdominal pain. Ann Nutr Metab. 2016; 68; 8–17.
• 3. Soares RL. Irritable bowel syndrome: A clinical review. World J Gastroenterol. 2014; 20: 12144-60.
• 4. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011; 17: 131–139.
• 5. Quigley EM. Current concepts of the irritable bowel syndrome. Scand J Gastroenterol Suppl. 2003; 237: 1-8.
• 6. Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017; 23(2): 151-63.
• 7. Costa ML, Oliveira JN, Tahan S, Morais MB. Overweight and constipation in adolescents. BMC Gastroenterol. 2011; 11: 40.
• 8. van Oijen MG, Josemanders DF, Laheij RJ, van Rossum LG, Tan AC, Jansen JB. Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med. 2006; 64: 45–9.
• 9. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004; 99: 1807–14.
• 10. Dong Y, Berens S, Eich W, Schaefert R, Tesarz J. Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study. BMJ Open. 2018; 8:e019453. Published 2018 Oct 17. doi:10.1136/bmjopen-2017-019453
• 11. Kibune NC, Garcia MC, Silva LS, Mesquita M. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities. Rev Esp Enferm Dig. 2016; 108: 59-64.
• 12. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002; 123: 2108-31.
• 13. Bai T, Xia J, Jiang Y, et al. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey. J Gastroenterol Hepatol. 2017; 32: 1018-25.
• 14. Aasbrenn M, Høgestø I, Eribe I et al. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: A cross-sectional study. BMC Obes. 2017; 4: 22.
• 15. Delgado-Aros S, Locke GR 3rd, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004; 99: 1801-6.
• 16. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004; 99: 1807-14.
• 17. Sadik R, Björnsson E, Simrén M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2010; 22: 102-8.
• 18. Kubo M, Fujiwara Y, Shiba M, et al. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterol Motil. 2011; 23: 249-54.